You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
大行評級|德銀:上調藥明康德評級至“買入” 公司展現良好的復甦勢頭
格隆匯 03-24 13:32

德銀髮表報告指,藥明康德去年收入392.41億元,毛利率按年增長0.2個百分點至40.8%,經調整淨利潤按年上升0.9%至99.51億元。去年第四季繼續保持增長勢頭,收入按年增長6.9%,按季增長10.3%。管理層預期增長勢頭將於今年第一季持續。

由於業務復甦及地緣政治局勢緩和,該行將其評級由“持有”升至“買入”,目標價從53.7港元升至83.4港元。該行認爲公司已展現良好的復甦勢頭,主要由TIDES業務所帶動,預測2024至2027年的營收年複合增長率爲12%,核心淨利年複合增長率爲16%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account